|
PKN2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6242562850266E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.77315972805081E-14 |
| Normal-vs-Stage2 |
2.55919999636589E-08 |
| Normal-vs-Stage3 |
5.52891066263328E-14 |
| Normal-vs-Stage4 |
3.8352654385676E-12 |
| Stage1-vs-Stage2 |
6.066400E-01 |
| Stage1-vs-Stage3 |
3.548000E-02 |
| Stage1-vs-Stage4 |
9.820100E-03 |
| Stage2-vs-Stage3 |
3.478200E-01 |
| Stage2-vs-Stage4 |
1.052450E-01 |
| Stage3-vs-Stage4 |
3.724200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.22044604925031E-16 |
| Normal-vs-AfricanAmerican |
1.047670E-04 |
| Normal-vs-Asian |
3.2328000276749E-09 |
| Caucasian-vs-AfricanAmerican |
4.515800E-01 |
| Caucasian-vs-Asian |
9.787000E-01 |
| AfricanAmerican-vs-Asian |
4.980200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.19109191795997E-13 |
| Normal-vs-Female |
1.62492241884138E-12 |
| Male-vs-Female |
9.475000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.48090004095758E-09 |
| Normal-vs-Age(41-60Yrs) |
8.34887714518118E-14 |
| Normal-vs-Age(61-80Yrs) |
1.74427139398858E-12 |
| Normal-vs-Age(81-100Yrs) |
2.058600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.049190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.012200E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.756200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.950400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.003800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.797200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.280400E-03 |
| Classical-VS-Follicular |
6.011200E-01 |
| Classical-VS-Other |
7.123400E-01 |
| Classical-VS-Normal |
2.52450005344684E-09 |
| Tall-VS-Follicular |
3.785700E-02 |
| Tall-VS-Other |
6.279700E-02 |
| Tall-VS-Normal |
6.53133103156733E-12 |
| Follicular-VS-Other |
6.397200E-01 |
| Follicular-VS-Normal |
2.89979995571343E-09 |
| Other-VS-Normal |
2.243700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.20774526332934E-14 |
| Normal-vs-N1 |
1.49879997302094E-09 |
| N0-vs-N1 |
7.349200E-01 |
|
|
